Arbutus Biopharma Logo
Arbutus Announces Resignation of Board Member
January 27, 2023 07:30 ET | Arbutus Biopharma Corporation
WARMINSTER, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...
DraftKings_FC.png
DraftKings to Release Fourth Quarter and Full Year 2022 Results on February 16, 2023, and Host Conference Call on February 17, 2023
January 27, 2023 07:30 ET | DraftKings Inc.
BOSTON, Jan. 27, 2023 (GLOBE NEWSWIRE) -- DraftKings Inc. (Nasdaq: DKNG) (the “Company” or “DraftKings”) today announced that it will release its fourth quarter and full year 2022 results after the...
logo.jpg
Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings
January 27, 2023 07:29 ET | Sol-Gel Technologies Ltd.
NESS ZIONA, Israel, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a dermatology company with FDA approvals for EPSOLAY® and TWYNEO®, two...
Allegro-MicroSystems-H-Tagline-TM-RGB.png
Polar Semiconductor Investment and Expansion
January 27, 2023 07:15 ET | Allegro MicroSystems, Inc.
MANCHESTER, N.H., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM) a global leader in power and sensing semiconductor technology for motion control and energy...
daseke-logo with (R) as of Aug 2015.jpg
Daseke, Inc. to Release Fourth-Quarter and Full-Year 2022 Results February 6, 2023
January 27, 2023 07:02 ET | Daseke, Inc.
ADDISON, Texas, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Daseke, Inc. (NASDAQ: DSKE) (or the “Company”), the premier North American transportation solutions specialist dedicated to servicing challenging...
STB_Investor-Placeholder.png
Stellar Bancorp, Inc. Reports Fourth Quarter 2022 Results
January 27, 2023 07:00 ET | Stellar Bancorp, Inc.
HOUSTON, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Stellar Bancorp, Inc. (the “Company” or “Stellar”) (NASDAQ: STEL) today reported net income of $2.1 million, or $0.04 earnings per diluted share, for the...
Wearable Devices Selected to Present at Best of CES 2023
January 27, 2023 07:00 ET | Wearable Devices Ltd.
The company was invited to present at the event highlighting trends and products from CES 2023 at The Paley Center for Media in New York City YOKNEAM ILLIT, ISRAEL, Jan. 27, 2023 (GLOBE...
logo.jpg
Sol-Gel Acquires Patidegib, a Phase 3, FDA-Breakthrough-Designated Orphan Product Candidate to Pursue Potential Market of Over $300 Million
January 27, 2023 07:00 ET | Sol-Gel Technologies Ltd.
Patidegib, an Orphan Drug candidate, broadens Sol-Gel’s pipeline with the potential to be the first therapy for preventing new basal cell carcinomas in Gorlin syndrome, if approved by the FDAPhase 3...
GDX_Logos_Blue_211220_01_600x208.jpg
GeneDx Holdings Announces Pricing Of A $150 Million Underwritten Public Offering Of Class A Common Stock And Concurrent Registered Direct Offering
January 27, 2023 06:00 ET | GeneDx Holdings Corp.
STAMFORD, Conn., Jan. 27, 2023 (GLOBE NEWSWIRE) -- GeneDx Holdings Corp. (Nasdaq: WGS) today announced the pricing of offerings for an aggregate of 428,571,429 shares of its Class A common stock at...
Dime-Bancshares-Logo-rgb.jpg
Dime Community Bancshares, Inc. Reports Strong Fourth Quarter 2022 Results With Earnings Per Share Increasing By 19% On a Year-Over-Year Basis
January 27, 2023 06:00 ET | Dime Community Bancshares, Inc.
Robust Loan Originations Drive Over $1.3 Billion in Loan Growth for Fiscal Year 2022 Fourth Quarter Results Highlighted by Strong Non-Interest Income Growth, Prudent Expense Management and Improved...